Stocks making the biggest moves premarket: PFE, PLTR, AAPL, ZBRA
Revvity shares rose 7% after raising its full-year EPS guidance to $5.40-$5.45. Pfizer reported Q3 earnings of 87 cents per share on $16.58B revenue, meeting expectations. Zebra Technologies fell 6% despite beating Q3 estimates, with lower free cash flow guidance. Gartner dropped 6% despite strong Q3 results and upbeat guidance. Yum Brands gained 1% after Q3 earnings beat estimates. Palantir fell 8% despite topping Q3 estimates and strong revenue growth.
How this was made
The 30-second read
Why it matters
Earnings surprises and guidance updates are driving immediate price volatility, offering short‑term trading opportunities.
Market read
The earnings releases create divergent price actions, influencing sector sentiment and offering immediate trade ideas.
What to watch
Free‑cash‑flow guidance for Zebra and broader macro backdrop could drive longer‑term trends beyond the immediate pre‑market moves.
Background
Premarket roundup highlighting the biggest price moves tied to fresh Q3 earnings releases across several major U.S. companies.
Ticker impact
Revvity raised full-year EPS guidance, driving a 7% pre‑market share gain.
likely upward pressure as investors price in higher earnings.
Guidance lift exceeds prior range and coincides with a sizable pre‑market rally.
Pfizer reported Q3 results that beat EPS expectations, moving flat pre‑market.
minimal short‑term move; price may stabilize.
Strong earnings but market already priced expectations.
Zebra Technologies posted better‑than‑expected Q3 results yet fell over 6% pre‑market.
downward pressure as investors focus on marginal free‑cash‑flow guidance.
Guidance miss on free cash flow outweighs earnings beat.
Gartner’s Q3 results beat expectations and it raised full‑year guidance, but shares slid over 6% pre‑market.
likely continued downside as market weighs broader tech sentiment.
Guidance improvement not enough to offset sector pressure.
Yum Brands posted Q3 earnings beat, lifting the stock about 1% pre‑market.
moderate upward bias as investors digest beat.
Beat aligns with modest price gain.
Palantir’s Q3 earnings topped estimates, yet shares fell nearly 8% pre‑market.
downward pressure as market reacts to profit‑taking.
Despite beat, large sell‑off indicates negative sentiment.
Apple missed iPad sales and margin forecasts, sending shares down nearly 4% pre‑market.
likely further decline as investors reassess outlook.
Guidance miss from a mega‑cap triggers notable sell‑off.
Market effects
Tech and healthcare earnings beats/misses influence sector sentiment.
U.S. pre‑market activity reflects broader market direction.
Large‑cap moves may affect global indices and investor risk appetite.
Counterpoint
Stocks like Palantir and Apple may be oversold after earnings beats/misses, presenting buying opportunities.
Key entities
- companyRevvity
Life‑sciences firm raising EPS guidance.
- companyPfizer
Pharma giant reporting Q3 results.
- companyZebra Technologies
Barcode scanner maker missing free‑cash‑flow guidance.
- companyGartner
Research firm beating estimates but shares fall.
- companyYum Brands
Restaurant operator beating earnings.
